Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT03308045
Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 4, 2017
Completion: Jun 1, 2021
NCT04207983
A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)
Phase: Phase 2
Start: Feb 3, 2020
Completion: Oct 5, 2021
NCT07024732
A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration
Phase: Phase 1
Start: Jul 31, 2025
Completion: Jun 30, 2026